藍英裝備(300293.SZ):藍英自控及中巨國際累計減持579.69萬股
格隆匯12月26日丨藍英裝備(300293.SZ)公佈,公司於近日收到控股股東藍英自控及其一致行動人中巨國際發來的《關於股份減持計劃進展的告知函》。藍英自控和中巨國際在2019年12月18日至2019年12月25日期間通過集中競價及大宗交易減持公司股份579.69萬股,公司控股股東及其一致行動人累計持股變動比例已達公司總股本1%。
此次減持後,藍英自控持有股份約1億股,佔總股本比例37.07%;中巨國際持有股份4055.13萬股,佔總股本比例15.02%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.